Validity of a Telemedicine System for the Evaluation of Acute-Phase Retinopathy of Prematurity
Graham E. Quinn(Children's Hospital of Philadelphia), Kelly C. Wade(Children's Hospital of Philadelphia), Ebenezer Daniel(University of Pennsylvania), Gui‐Shuang Ying(Philadelphia College of Osteopathic Medicine), Alex R. Kemper(Nationwide Children's Hospital), Anna L. Ells(University of Calgary), Agnieshka Baumritter(Children's Hospital of Philadelphia), P. Lloyd Hildebrand(University of Oklahoma Health Sciences Center), Eleanor Schron(National Institutes of Health)
Cited by 209
Related Papers
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
|Ophthalmology|2012|1.7k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|857
Diabetic Retinopathy Preferred Practice Pattern®
|Ophthalmology|2019|703